Skip to content

A systems biology approach towards understanding and treating non-neovascular age-related macular degeneration

Research output: Contribution to journalArticle

  • JT Handa
  • C Bowes Rickman
  • Andrew Dick
  • M B Gorin
  • J W Miller
  • C A Toth
  • M Ueffing
  • M Zarbin
  • L A Farrer
Original languageEnglish
Article number3347
Number of pages11
JournalNature Communications
Issue number1
DateAccepted/In press - 3 Jul 2019
DatePublished (current) - 26 Jul 2019


Age-related macular degeneration (AMD) is the most common cause of blindness among the elderly in the developed world. While treatment is effective for the neovascular or "wet" form of AMD, no therapy is successful for the non-neovascular or "dry" form. Here we discuss the current knowledge on dry AMD pathobiology and propose future research directions that would expedite the development of new treatments. In our view, these should emphasize system biology approaches that integrate omic, pharmacological, and clinical data into mathematical models that can predict disease onset and progression, identify biomarkers, establish disease causing mechanisms, and monitor response to therapy.

Download statistics

No data available



  • Full-text PDF (final published version)

    Rights statement: This is the final published version of the article (version of record). It first appeared online via Springer Nature at . Please refer to any applicable terms of use of the publisher.

    Final published version, 1.57 MB, PDF document

    Licence: CC BY


View research connections

Related faculties, schools or groups